Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange Detected- Added a government funding lapse notice and operating status guidance, and a link to official status pages. - Updated software version from v3.1.0 to v3.2.0.SummaryDifference5%
- Check23 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0 with no other content changes provided.SummaryDifference0.1%
- Check37 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check51 days agoChange DetectedThe page has been updated to include specific details about uveal melanoma treatments and their associated drugs, while also removing a significant amount of related content and terminology. The facility name and location details have been clarified.SummaryDifference5%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.